Pair Name | Methylselenocysteine, Etoposide | ||
Phytochemical Name | Methylselenocysteine (PubChem CID: 147004 ) | ||
Anticancer drug Name | Etoposide (PubChem CID: 36462 ) | ||
Structure of Phytochemical |
Download
2D
MOL
3D
MOL
|
||
Structure of Anticancer Drug |
Download
2D
MOL
3D
MOL
|
Pair Name | Methylselenocysteine, Etoposide | |||
Disease Info | [ICD-11: 2C77] | Cervical cancer | Investigative | |
Biological Phenomena | Induction-->Gap junction activity | |||
Gene Regulation | Up-regulation | Expression | GJB1 | hsa2705 |
Up-regulation | Expression | GJB2 | hsa2706 | |
In Vitro Model | HeLa | Human papillomavirus-related cervical adenocarcinoma | Homo sapiens (Human) | CVCL_0030 |
Result | We provide the novel finding that MSC increases etoposide-mediated cytotoxicity by enhancing GJ activity, due to elevated Cx expression through a GSH-dependent posttranscriptional mechanism. More generally, the study highlights potential benefit of the combination of GJ modulators and chemotherapeutic agents in anticancer treatment. |
No. | Title | Href |
---|---|---|
1 | Methylselenocysteine Potentiates Etoposide-Induced Cytotoxicity by Enhancing Gap Junction Activity. Biol Pharm Bull. 2022;45(4):467-476. doi: 10.1248/bpb.b21-00893. | Click |